Paolo LaColla
6Patents
4h-index
9Co-inventors
46Inventor score
Filing activity: Jun 27, 2003 → Nov 13, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7456155B2 | 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | Human Necessities | 64 | Expired |
| US7582618B2 | 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | Human Necessities | 58 | Active |
| US7824851B2 | 2′-branched nucleosides and Flaviviridae mutation | Emerging Cross-Sectional Technologies | 54 | Expired |
| US8674085B2 | 2′-branched nucleosides and Flaviviridae mutation | Emerging Cross-Sectional Technologies | 27 | Active |
| US7365090B2 | Substituted phenylindoles for the treatment of HIV | Chemistry; Metallurgy | 0 | Expired |
| US9968628B2 | Methods and compositions for treating flaviviruses and pestiviruses | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.